Cargando…

Factor V Leiden G1691A and prothrombin G20210A mutations among Palestinian patients with sickle cell disease

BACKGROUND: Vascular thrombosis is an important pathophysiological aspect of sickle cell disease (SCD). This study aimed to investigate the prevalence and clinical impact of factor V Leiden G1691A (FVL) and prothrombin G20210A mutations among Palestinian sickle cell disease (SCD) patients. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samarah, Fekri, Srour, Mahmoud A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771009/ https://www.ncbi.nlm.nih.gov/pubmed/29372059 http://dx.doi.org/10.1186/s12878-018-0097-0

Ejemplares similares

Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome
por: Padda, Jaskamal, et al.
Publicado: (2021)

Large‐scale screening for factor V Leiden (G1691A), prothrombin (G20210A), and MTHFR (C677T) mutations in Greek population
por: Raptopoulou, Alkistis, et al.
Publicado: (2022)

Factor-V Leiden G1691A and prothrombin G20210A polymorphisms in Sudanese women with preeclampsia, a case -control study
por: Ahmed, Nadir A., et al.
Publicado: (2019)

MTHFR C677T, Prothrombin G20210A, and Factor V Leiden (G1691A) Polymorphism and Beta-Thalassemia Risk: A Meta-Analysis
por: Nigam, Nitu, et al.
Publicado: (2020)

Prevalence of Factor V Leiden G1691A and Prothrombin G20210A Gene Mutation Among Pregnant Women: Experience from a Multi-Center Study in Nigeria
por: John-Olabode, Sarah O, et al.
Publicado: (2021)

Direct‐to‐consumer genetic testing for factor V Leiden and prothrombin 20210G>A: the consumer experience
por: Elson, Sarah L., et al.
Publicado: (2020)

The Combined Heterozygosity of Factor V Leiden and G20210A Prothrombin Gene Mutation in a Patient With Venous Thromboembolism
por: Machado, Marcia, et al.
Publicado: (2023)

Factor V Leiden and Prothrombin 20210A Mutations among Turkish Pediatric Leukemia Patients
por: Akın, Dilara Fatma, et al.
Publicado: (2012)

Risk of Budd-Chiari Syndrome Associated with Factor V Leiden and G20210A Prothrombin Mutation: A Meta-Analysis
por: Zhang, Peijin, et al.
Publicado: (2014)

The Role of Factor V Leiden, Prothrombin G20210A, and MTHFR C677T Mutations in Neonatal Cerebral Sinovenous Thrombosis
por: Garrido-Barbero, Maria, et al.
Publicado: (2019)

Thrombophilic Risk of Factor V Leiden, Prothrombin G20210A, MTHFR, and Calreticulin Mutations in Essential Thrombocythemia Egyptian Patients
por: El-Ghonemy, Mohamed S., et al.
Publicado: (2020)

Acute Myocardial Infarction in Patients with Hereditary Thrombophilia—A Focus on Factor V Leiden and Prothrombin G20210A
por: Badescu, Minerva Codruta, et al.
Publicado: (2023)

Epidemiology of Prothrombin G20210A Mutation in the Mediterranean Region
por: Jadaon, Mehrez M.
Publicado: (2011)

Association of Factor V Leiden and Prothrombin G20210A Polymorphisms in Women with Recurrent Pregnancy Loss in Isfahan Province, Iran
por: Kardi, Mohammad Taghi, et al.
Publicado: (2018)

Prevalence of the prothrombin G20210A mutation among ischemic stroke patients
por: Ahmed, Salar A., et al.
Publicado: (2020)

The impact of prothrombin (G20210A) gene mutation on stroke in youths
por: Saadatnia, Mohammad, et al.
Publicado: (2012)

Mutation in the Prothrombin Gene G20210A as a Cause of Cerebral Venous Thrombosis
por: Arroyave, Jorge A., et al.
Publicado: (2012)

Painless Livedoid Vasculopathy in a Patient with G20210A Prothrombin Gene Mutation
por: Mirrakhimov, Aibek E., et al.
Publicado: (2012)

Pregnancy complications in G20210A mutation carriers associated with high prothrombin activity
por: Nikolaeva, M. G., et al.
Publicado: (2021)

Association of G20210A Prothrombin Gene Mutation and Cerebral Ischemic Stroke in Young Patients
por: Poudel, Sujan, et al.
Publicado: (2020)

Factor V Leiden 1691G > A mutation and the risk of recurrent pregnancy loss (RPL): systematic review and meta-analysis
por: Eslami, Mohammad Masoud, et al.
Publicado: (2020)

Prevalence of Anemia and Iron Deficiency among Palestinian Pregnant Women and Its Association with Pregnancy Outcome
por: Srour, Mahmoud A., et al.
Publicado: (2018)

Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss
por: Teremmahi Ardestani, Majid, et al.
Publicado: (2013)

Factor VLeiden and Prothrombin G20210A Gene Polymorphisms in Patients with Coronary Artery Disease
por: Ercan, Bahadır, et al.
Publicado: (2008)

Frequency and association of 1691 (G>A) FVL, 20210 (G>A) PT and 677 (C>T) MTHFR with deep vein thrombosis in the population of Bosnia and Herzegovina
por: Jusić-Karić, A, et al.
Publicado: (2016)

Cerebral venous sinus thrombosis in heterozygous prothrombin G20210A mutation in Egyptian child, with an excellent outcome
por: Attia, Tarek Hamed, et al.
Publicado: (2015)

Genetic correlation between Prothrombin G20210A polymorphism and retinal vein occlusion risk
por: Zou, Yuanyuan, et al.
Publicado: (2019)

Prothrombin Gene G20210A Variant in Angiographically Documented Patients with Coronary Artery Stenosis
por: Pourgholi, Leyla, et al.
Publicado: (2019)

Prothrombin Gene G20210A Mutation in Acute Deep Venous Thrombosis Patients with Poor Response to Warfarin Therapy
por: Attia, F.M, et al.
Publicado: (2009)

Cerebral Venous Sinus Thrombosis with Bilateral Abducens Palsy in a Patient with Heterozygous Prothrombin G20210A Mutation
por: Sodavarapu, Soujanya, et al.
Publicado: (2019)

Plasma Lipids and Lipoproteins in Sickle Cell Disease Patients in the Northern West Bank, Palestine
por: Samarah, Fekri, et al.
Publicado: (2021)

Allele frequency distribution of 1691G>A F5 (which confers Factor V Leiden) across Europe, including Slavic populations
por: Clark, Jeremy S. C., et al.
Publicado: (2013)

Factor V Leiden but not the factor II 20210G>A mutation is a risk factor for premature coronary artery disease: a case-control study in Iran
por: Agosti, Pasquale, et al.
Publicado: (2023)

Frequency of Red Blood Cell Alloimmunization in Patients with Sickle Cell Disease in Palestine
por: Samarah, Fekri, et al.
Publicado: (2018)

The Association of Coagulation Factor V (Leiden) and Factor II (Prothrombin) Mutations With Stroke
por: Pirhoushiaran, Maryam, et al.
Publicado: (2014)

Prevalence and Geographical Variation of Prothrombin G20210A Mutation in Patients with Cerebral Vein Thrombosis: A Systematic Review and Meta-Analysis
por: Gonzalez, Joaquín V., et al.
Publicado: (2016)

Prothrombin G20210A Gene Mutation-Induced Recurrent Deep Vein Thrombosis and Pulmonary Embolism: Case Report and Literature Review
por: Elkattawy, Sherif, et al.
Publicado: (2022)

The role of FV 1691G>A, FII 20210G>A mutations and MTHFR 677C>T; 1298A>C and 103G>T FXIII gene polymorphisms in pathogenesis of intraventricular hemorrhage in infants born before 32 weeks of gestation
por: Szpecht, Dawid, et al.
Publicado: (2017)

PlA2 Polymorphism of Platelet Glycoprotein IIb/IIIa and C677T Polymorphism of Methylenetetrahydrofolate Reductase (MTHFR), but Not Factor V Leiden and Prothrombin G20210A Polymorphisms, Are Associated with More Severe Forms of Legg–Calvé–Perthes Disease
por: García-Alfaro, María Dolores, et al.
Publicado: (2021)

Thrombophilic Genetic Factors PAI-1, MTHFRC677T, V Leiden 506Q, and Prothrombin 20210A in Noncirrhotic Portal Vein Thrombosis and Budd-Chiari Syndrome in a Caucasian Population
por: D'Amico, Mario, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_n4g4q30eh3822qfal8j8hlem9s